Analyst Ratings for MPLX
Analysts have provided the following ratings for MPLX (NYSE:MPLX) within the last quarter:
UBS Maintains Buy on MPLX, Lowers Price Target to $40
UBS analyst Joseph Parkhill maintains MPLX (NYSE:MPLX) with a Buy and lowers the price target from $41 to $40.
Ominous Death Cross Forms On MPLX’s Chart
If history is any guide, there may be trouble ahead for shares of MPLX (NYSE:MPLX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
MPLX’s Return On Capital Employed Insights
Pulled from Benzinga Pro data, MPLX (NYSE:MPLX) posted Q1 earnings of $833.00 million, an increase from Q4 of 0.6%. Sales dropped to $2.61 billion, a 4.54% decrease between quarters.
7 Best Energy Stocks To Buy With Over 6% Dividend Yields: Ecopetrol, Energy Transfer LP And More
One of the only sectors of the market that is skyrocketing amid broad market weakness in 2022 is the energy sector.
MPLX: Q1 Earnings Insights
MPLX (NYSE:MPLX) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:10 AM.
Here's what investors need to know about the announcement.
Earnings
MPLX beat estimated earnings by 2.63%, reporting an EPS of $0.78 versus an estimate of $0.76.
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
MPLX Reports Co., WhiteWater Midstream, Joint Venture Between Stonepeak, West Texas Gas Reached Final Investment Decision To Move Forward With Expansion Of Whistler Pipeline
MPLX LP (NYSE:MPLX), WhiteWater Midstream, and a joint venture between Stonepeak Infrastructure Partners and West Texas Gas, Inc. have reached a final investment decision to move forward with the expansion of the
Truist Securities Assumes MPLX at Buy, Announces Price Target of $37
Truist Securities analyst Neal Dingmann assumes MPLX (NYSE:MPLX) with a Buy rating and announces Price Target of $37.
Raymond James Maintains Outperform on MPLX, Raises Price Target to $37
Raymond James analyst Justin Jenkins maintains MPLX (NYSE:MPLX) with a Outperform and raises the price target from $35 to $37.